ABLE Financial Group’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.66M Buy
16,422
+2,346
+17% +$243K 0.28% 75
2026
Q1
$1.36M Sell
14,076
-289
-2% -$29.6K 0.27% 72
2025
Q4
$1.52M Buy
14,365
+394
+3% +$45.7K 0.31% 64
2025
Q3
$1.77M Buy
13,971
+1,103
+9% +$131K 0.38% 56
2025
Q2
$1.58M Sell
12,868
-388
-3% -$44.3K 0.38% 59
2025
Q1
$1.34M Buy
13,256
+728
+6% +$71.1K 0.38% 50
2024
Q4
$1.16M Buy
12,528
+2,100
+20% +$206K 0.34% 57
2024
Q3
$1.01M Buy
10,428
+25
+0.2% +$2.25K 0.31% 56
2024
Q2
$892K Buy
10,403
+478
+5% +$40.1K 0.32% 57
2024
Q1
$820K Buy
9,925
+191
+2% +$14K 0.32% 59
2023
Q4
$649K Buy
9,734
+2,184
+29% +$141K 0.28% 66
2023
Q3
$507K Buy
+7,550
New +$519K 0.25% 73

Other funds holding EHC

ABLE Financial Group's EHC Position: Q2 2026 in Review

ABLE Financial Group increased its Encompass Health (EHC) stake by 17% in Q2 2026, buying an estimated $243K and bringing the position to 16,422 shares worth $1.66M. The position accounts for 0.28% of the portfolio, ranked #75.

ABLE Financial Group first reported a position in EHC in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.77M in Q3 2025. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • ABLE Financial Group held 16,422 shares of Encompass Health worth $1.66M as of Q2 2026.
  • ABLE Financial Group bought 2,346 Encompass Health shares in Q2 2026, an estimated $243K.
  • Encompass Health made up 0.28% of ABLE Financial Group's portfolio in Q2 2026, its #75 holding.
  • ABLE Financial Group first reported a position in Encompass Health in Q3 2023 and has held it in 12 quarters since.
  • ABLE Financial Group's Encompass Health position peaked at $1.77M in Q3 2025.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on ABLE Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.